ATYR
aTyr Pharma·NASDAQ
--
--(--)
--
--(--)
ATYR fundamentals
aTyr Pharma (ATYR) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.22 (YoY +4.35%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.22
+4.35%
Report date
Aug 7, 2025
Earnings Call
7:00 AM on Aug 7, 2025
Meeting link.EPS
Actual | 0.25 | -0.69 | -0.68 | -0.47 | -0.51 | -0.64 | -0.42 | -0.31 | -0.44 | -0.44 | -0.46 | -0.26 | -0.29 | -0.22 | -0.2 | -0.25 | -0.23 | -0.23 | -0.23 | -0.18 | -0.17 | -0.22 | |||||||||
Forecast | -0.18 | -0.73 | -0.7433 | -0.8233 | -0.3175 | -0.508 | -0.5929 | -0.2833 | -0.316 | -0.382 | -0.4633 | -0.48 | -0.35 | -0.2786 | -0.226 | -0.238 | -0.25 | -0.2533 | -0.22 | -0.2256 | -0.191 | -0.1845 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +238.89% | +5.48% | +8.52% | +42.91% | -60.63% | -25.98% | +29.16% | -9.42% | -39.24% | -15.18% | +0.71% | +45.83% | +17.14% | +21.03% | +11.50% | -5.04% | +8.00% | +9.20% | -4.55% | +20.21% | +10.99% | -19.24% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.06M | 189.00K | 148.00K | 2.05M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10.39M | 0 | 0 | 353.00K | 0 | 235.00K | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.40M | 399.10K | 103.33K | 126.00K | 3.98M | 621.80K | 266.67K | 2.52M | 200.00K | 2.50M | 400.00K | 357.14K | 2.36M | 611.67K | 1.50M | 3.42M | 36.67K | 60.00K | 21.67K | 15.56K | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +83.33% | -52.64% | +43.23% | +1529.37% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% | +2808.08% | -100.00% | -100.00% | -76.47% | -100.00% | +540.90% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did aTyr Pharma beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for aTyr Pharma year over year?What were the key takeaways from aTyr Pharma’s earnings call?What does aTyr Pharma do and what are its main business segments?What were the key takeaways from aTyr Pharma's earnings call?What is aTyr Pharma's latest dividend and current dividend yield?What is the market's earnings forecast for aTyr Pharma next quarter?What guidance did aTyr Pharma's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
